Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03332355
Title Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 2
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Vanquish Oncology, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Illinois at Chicago Chicago Illinois 60612 United States Details
Johns Hopkins Cancer Center Baltimore Maryland 21231 United States Details
Regions Hospital Saint Paul Minnesota 55101 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field